BC
Brunswick Corporation
BC has the edge over RIVN overall, supported by stronger fundamentals and lower modeled downside.
RIVN
Rivian Automotive, Inc.
RIVN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BC's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $31.76 | -58% |
| Fair | 14x | $45.28 | -41% |
| Forward | 14x | $76.50 | — |
| Expensive | 21x | $69.06 | -9.7% |
| Current | 23x | $76.50 | — |
Historical ranges are pointers, not guarantees.
BC's PE is in its expensive range at 23x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
BC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BC, with profitability improving.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.33 | +63% |
| Q3 2026 | $3.27 | +$6.88 |
| Q2 2026 | -$1.27 | -295% |
| Q1 2026 | -$2.06 | -266% |
| Q4 2025 | -$2.08 | -208% |
| Q3 2025 | -$3.61 | -190% |
| Q2 2025 | $0.65 | -87% |
| Q1 2025 | $1.24 | -77% |
| Q4 2024 | $1.93 | -68% |
BC has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
BC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +6.9% |
| Q2 2026 | $1.6B | +7.7% |
| Q1 2026 | $1.4B | +13% |
| Q4 2025 | $1.3B | +15% |
| Q3 2025 | $1.4B | +6.8% |
| Q2 2025 | $1.4B | +0.2% |
| Q1 2025 | $1.2B | -10% |
| Q4 2024 | $1.2B | -15% |
BC's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +25 points |
| Q2 2026 | 8.3% | +1.2 points |
| Q1 2026 | 3.6% | -1 points |
| Q4 2025 | 3.1% | +8 points |
| Q3 2025 | -18% | -26 points |
| Q2 2025 | 7.1% | -3.8 points |
| Q1 2025 | 4.6% | -3.5 points |
| Q4 2024 | -4.8% | -13 points |
BC has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN has the edge over BC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
BC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $136.4M | +28% |
| Q2 2026 | $272.4M | +0.4% |
| Q1 2026 | -$121.3M | -$56.2M |
| Q4 2025 | $83.6M | -70% |
| Q3 2025 | $106.5M | +239% |
| Q2 2025 | $271.3M | +66% |
| Q1 2025 | -$65.1M | +$142.3M |
| Q4 2024 | $276.1M | +22% |
BC has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
BC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -400K shares |
| 1 year | -0.9% | -600K shares |
| 3 years | -7% | -4.9M shares |
| 5 years | -17% | -13.2M shares |
| Available history | -24% | -20.5M shares |
BC has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28.8M |
| Q2 2026 | $15M |
| Q1 2026 | $16.2M |
| Q4 2025 | $15M |
| Q3 2025 | $21.9M |
| Q2 2025 | $17.5M |
| Q1 2025 | $25.6M |
| Q4 2024 | $10M |
BC spent $75M buying back its own shares over the past year, about the same as the year before.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
BC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 6.5x | High |
| Q1 2026 | 8.1x | High |
| Q4 2025 | 7.3x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 3.5x | Elevated |
BC's net debt is about 2.8 years of its operating earnings (EBITDA), down from 12 years a year ago.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 65.3 | Neutral |
BC's weekly RSI is 53 (neutral) and its Stochastic is 65 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
BC PE vs Consumer Cyclical Sector
| Metric | BC | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 30% above |
| PE % | 87 | 47 | 40 pts above |
BC is trading at 23x earnings, a 30% premium to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
BC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.2 | 11% above |
| 20 week MA | $74.2 | 3.1% above |
| 50 week MA | $77.4 | 1.2% below |
| 100 week MA | $68.6 | 11% above |
| 200 week MA | $75.3 | 1.6% above |
BC has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
BC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.8 | $81.5 | +34% |
| 2021 | $81.5 | $96.9 | +19% |
| 2022 | $96.9 | $71.4 | -26% |
| 2023 | $71.4 | $96.8 | +35% |
| 2024 | $96.8 | $64.7 | -33% |
| 2025 | $64.7 | $76.1 | +18% |
| 2026 YTD | $76.1 | $76.5 | +0.5% |
BC has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.